Terrill Dicki
Nov 18, 2025 03:45
NVIDIA and Los Alamos National Laboratory are pioneering AI co-scientists to enhance fusion research and cancer treatment, leveraging AI for accelerated scientific discovery.
Artificial intelligence (AI) is playing a transformative role in advancing scientific research, with NVIDIA and Los Alamos National Laboratory (LANL) at the forefront of this innovation. The collaboration focuses on developing AI co-scientists, designed to accelerate discovery in fields such as inertial confinement fusion (ICF) and cancer treatment, according to NVIDIA.
AI Co-Scientist for Fusion Research
The AI co-scientist initiative aims to tackle the complex challenges of ICF, a process that replicates the energy generation of stars here on Earth. This process involves using lasers to compress and heat fuel pellets, leading to nuclear fusion. However, the predictability of such experiments remains a significant challenge due to the intricate interplay of physical phenomena. By utilizing AI, LANL and NVIDIA are working towards enhancing the accuracy and efficiency of fusion research.
The AI co-scientist leverages the NVIDIA NeMo framework to curate data, pretrain models, and apply reinforcement learning, transforming the Llama Nemotron Super 1.5 model into a domain-aware reasoning tool. This approach aims to improve the performance of ICF experiments at facilities like the National Ignition Facility and the OMEGA laser.
AI Co-Scientist for Cancer Treatment
In the realm of medicine, the AI co-scientist is proving invaluable in the development of targeted alpha therapy (TAT) for cancer treatment. TAT uses radioactive atoms to destroy cancer cells, but precise targeting is crucial to avoid damaging healthy tissue. The AI platform developed by LANL integrates generative AI and simulation to discover new chelator molecules that can enhance the delivery and efficacy of TAT.
This AI-driven process involves generating hypotheses, testing molecular designs, and using high-performance simulations to predict chemical properties. The collaboration has already identified molecules with improved binding properties, highlighting the potential for AI to accelerate the development of more effective cancer therapies.
Implications and Future Directions
The integration of AI co-scientists in scientific research is a promising development that could revolutionize multiple fields. By combining human expertise with AI’s data processing capabilities, researchers can generate and test hypotheses more efficiently, leading to faster breakthroughs in energy and medicine.
Mark Chadwick, Associate Laboratory Director for Simulation, Computing, and Theory, emphasized the significance of these AI co-scientists in addressing humanity’s grand challenges. As the technology evolves, it promises to provide more profound insights and solutions across various scientific disciplines.
This pioneering work, supported by resources from the Perlmutter supercomputer and the National Energy Research Scientific Computing Center, underscores the growing role of AI in advancing scientific discovery.
Image source: Shutterstock
Source: https://blockchain.news/news/ai-co-scientists-revolutionize-fusion-research-and-cancer-treatment
